arrow
A

Aldo Manzin

university of cagliari
H指数:39
被引数:5,170

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of peripheral biomarkers through metabolomic analysis in patients with bipolar disorder treated with mood stabilizers: an exploratory study

通过代谢组学分析鉴定接受情绪稳定剂治疗的双相障碍患者的周围生物标志物:一项探索性研究

2025-10-010
OAAI
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study

SARS-CoV-2疫苗接种和感染对免疫介导性疾病患者体液和细胞免疫的影响: 一项初步研究

2024-06-141
OAAI
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose

ChAdOx1 nCoV-19和BNT162b2加强剂量的异源引发疫苗接种后,对野生型和古老的BA.1 SARS-CoV-2变体的体液反应

2024-01-201
OAAI
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic

通过新型冠状病毒肺炎大流行,暴露于疫苗接种和感染对CVID患者对SARS-CoV-2的细胞和抗体反应的影响

2023-12-221
PRE
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients
2023-10-281
OAAI
Design of Three Residues Peptides against SARS-CoV-2 Infection

抗SARS-CoV-2感染三残基多肽的设计

2022-09-2211
OAAI
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy

评估接受b细胞消耗疗法的患者对第三剂BNT162b2 mRNA新型冠状病毒肺炎疫苗的体液和细胞反应

2022-07-019
OA
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination

BNT162b2疫苗接种后长达9个月的撒丁岛队列组中针对SARS-CoV-2的中和抗体反应

2022-03-295
OAAI